EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Self-reported health, neuropsychological tests and biomarkers in fully recovered COVID-19 patients vs patients with post-COVID cognitive symptoms: A pilot study

Michael R Lawrence, Judith E Arnetz iD, Scott E Counts, Aiesha Ahmed, Bengt B Arnetz iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0315486 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Michael R Lawrence und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Neuropsychology, Corewell Health, Grand Rapids, Michigan, United States of America. Hauptthemen laut MEDLINE: COVID-19, Cognitive Dysfunction. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Spectrum Health Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Substantial numbers of individuals who contract COVID-19 experience long-lasting cognitive symptoms such as brain fog. Yet research to date has not compared these patients with healthy controls with a history of laboratory-confirmed COVID-19 infection, making it difficult to understand why certain COVID patients develop post-COVID cognitive symptoms while others do not. The objective of this pilot study was to compare two groups of laboratory-confirmed post-COVID patients, with and without cognitive symptoms, on measures of cognitive and psychological functioning, self-reported perceptions of functional status and quality of life, and biomarkers of stress, inflammation, and neuroplasticity. Using a case-control design, 17 participants were recruited from a healthcare system in western Michigan, USA in 2022–2024. All participants were aged 25–65 and had a positive polymerase chain reaction (PCR) test confirming previous COVID-19 infection. Ten participants reported cognitive symptoms (long COVID group) while seven were fully recovered with no residual symptoms (controls). All participants underwent an interview on their self-rated health and quality of life, a battery of neurocognitive tests, and blood draw for biomarker analysis. No group differences were detected for neuropsychological test measures except for letter fluency where the long COVID group scored significantly lower (p < .05). The long COVID group had significantly lower ratings than controls on quality of life, physical health, emotional functioning, and psychological well-being. Serum levels of nerve growth factor (NGF), a biomarker of brain plasticity, were significantly lower in the long COVID group, which was significantly more likely than controls to have serum levels of inflammatory marker (interleukin (IL)-10) values greater than or equal to the median (p = 0.015). Biomarker analyses suggest possible prolonged inflammatory processes in long COVID patients compared to fully recovered patients. Results of decreased neuroplastic functioning give credence to patients’ reports of post-COVID changes in brain function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Cognitive DysfunctionHumansMiddle AgedPilot ProjectsMaleFemaleBiomarkersAdultSelf ReportNeuropsychological TestsAgedCase-Control StudiesQuality of LifeSARS-CoV-2

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Division of Clinical Neuropsychology, Corewell Health, Grand Rapids, Michigan, United States of America.
  • Department of Neurology, Corewell Health, Grand Rapids, Michigan, United States of America.
  • Department of Family Medicine, College of Human Medicine, Grand Rapids, Michigan, United States of America.
  • Department of Translational Neuroscience, College of Human Medicine, Grand Rapids, Michigan, United States of America.

ORCID-Profile: Judith E Arnetz, Bengt B Arnetz

Förderung

  • Spectrum Health Foundation

Zitieren

APA

Lawrence, M. R., Arnetz, J. E., Counts, S. E., Ahmed, A., & Arnetz, B. B. (2025). Self-reported health, neuropsychological tests and biomarkers in fully recovered COVID-19 patients vs patients with post-COVID cognitive symptoms: A pilot study. PLOS One. https://doi.org/10.1371/journal.pone.0315486

Vancouver

Lawrence MR, Arnetz JE, Counts SE, Ahmed A, Arnetz BB. Self-reported health, neuropsychological tests and biomarkers in fully recovered COVID-19 patients vs patients with post-COVID cognitive symptoms: A pilot study. PLOS One. 2025. doi:10.1371/journal.pone.0315486

BibTeX
@article{Lawrence2025,
  author = {Lawrence, Michael R and Arnetz, Judith E and Counts, Scott E and Ahmed, Aiesha and Arnetz, Bengt B},
  title = {Self-reported health, neuropsychological tests and biomarkers in fully recovered COVID-19 patients vs patients with post-COVID cognitive symptoms: A pilot study},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0315486}
}
Kostenlos starten →